Biological drug development in Biotech and Big Pharma

Add to your list(s) Download to your calendar using vCal

• Paul G Varley, VP Biopharmaceutical Development, Kymab, a Sanofi company.
• Monday 24 May 2021, 13:30-14:30
• Zoom link - Register on Eventbrite for zoom link.

If you have a question about this talk, please contact Suzanne Boone.

https://www.eventbrite.co.uk/e/industry-lecture-paul-varley-of-kymab-tickets-140964288983

This talk will give an overview of the development of biological medicines with a focus on monoclonal antibody R&D from 25 years ago to the present. This will include consideration of the importance of measurement and resultant understanding of the complex systems used for manufacturing biologic drugs so that they ultimately can benefit patients. The talk will be from an industrial scientist’s from both a Biotech. and “Big Pharma” perspective. It will consider the importance of vision with “the end in mind” to drive the science and innovation that has enabled the huge success of this class of medicine. Looking to the future the talk will also touch on the response to the pandemic and how that has the potential to transform development in the future.

This talk is part of the Sensors CDT seminars series.

This talk is included in these lists:

• All Talks (aka the CURE list)
• CamBridgeSens
• Cambridge talks
• Chemical Engineering and Biotechnology
• Featured lists
• ME Seminar
• School of Technology
• Sensors CDT seminars
• Trust & Technology Initiative - interesting events
• Zoom link - Register on Eventbrite for zoom link

Note that ex-directory lists are not shown.